Membranous nephropathy associated with hepatitis C virus infection treated with corticosteroids and Ledipasvir-Sofosbuvir: a case report and review of literature

被引：8
|
作者：
Weng, Qinjie [1 ]
Li, Xiao [1 ]
Ren, Hong [1 ]
Xie, Jingyuan [1 ]
Pan, Xiaoxia [1 ]
Xu, Jing [1 ]
Chen, Nan [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Nephrol, Shanghai 200030, Peoples R China
来源：
ONCOTARGET | 2017年 / 8卷 / 13期
关键词：
hepatitis C virus; membranous nephropathy; hepatitis C virus-related glomerulonephritis; Ledipasvir-Sofosbuvir; case report; GENOTYPE; 1; INFECTION; KIDNEY-DISEASE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; RENAL-DISEASE; HCV; THERAPY; JAPAN; PLUS;
D O I：
10.18632/oncotarget.15397
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adults. As many clinical cases have reported, it may be associated with hepatitis C virus (HCV) infection. Antiviral therapy can be various. Case summary: We report a case of patient with chronic HCV infection and MN, who presented with was proteinuria. He was treated with ledipasvir and sofosbuvir (Harvoni; Gilead Sciences, Foster City, CA) and was found to be virus-free. Conclusion: We have reported this case to provide insight into whether Ledipasvir-Sofosbuvir should be administered for HCV-related glomerulonephritis.
引用
收藏
页码：22299 / 22303
页数：5
相关论文
共 50 条
  • [21] The Safety and Effectiveness of Ledipasvir-Sofosbuvir in Adolescents 12-17 Years Old With Hepatitis C Virus Genotype 1 Infection
    Balistreri, William F.
    Murray, Karen F.
    Rosenthal, Philip
    Bansal, Sanjay
    Lin, Chuan-Hao
    Kersey, Kathryn
    Massetto, Benedetta
    Zhu, Yanni
    Kanwar, Bittoo
    German, Polina
    Svarovskaia, Evguenia
    Brainard, Diana M.
    Wen, Jessica
    Gonzalez-Peralta, Regino P.
    Jonas, Maureen M.
    Schwarz, Kathleen
    HEPATOLOGY, 2017, 66 (02) : 371 - 378
  • [22] Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation
    Ciesek, S.
    Proske, V.
    Otto, B.
    Pischke, S.
    Costa, R.
    Luethgehetmann, M.
    Polywka, S.
    Klempnauer, J.
    Nashan, B.
    Manns, M. P.
    von Hahn, T.
    Lohse, A. W.
    Wedemeyer, H.
    Mix, H.
    Sterneck, M.
    TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (03) : 326 - 332
  • [23] Autoimmune Hepatitis During Ledipasvir/Sofosbuvir Treatment of Hepatitis C: A Case Report
    Covini, Giovanni
    Bredi, Elena
    Badalamenti, Salvatore
    Roncalli, Massimo
    Aghemo, Alessio
    Colombo, Massimo
    HEPATOLOGY COMMUNICATIONS, 2018, 2 (10) : 1179 - 1183
  • [24] Sexual Dysfunction in a Patient Taking Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C: A Case Report
    Lenz, Destin U.
    Crutcher, Effie L.
    Greene, Elisa M.
    JOURNAL OF PHARMACY PRACTICE, 2019, 32 (02) : 231 - 235
  • [25] The effectiveness and safety of sofosbuvir-ledipasvir for patients with hepatitis C virus genotype 2 infection
    Chen, Po-Yueh
    Yang, Hsin-Yi
    Chou, Chu-Kuang
    Chang, Li-Jen
    Hsu, Ming-Tse
    Tsai, Tsung-Jung
    Fang, Chien-Chung
    Su, Chang-Chao
    Lin, Yu-Ling
    Feng, Yu-Ming
    Chen, Chi-Yi
    ADVANCES IN DIGESTIVE MEDICINE, 2022, 9 (02) : 91 - 97
  • [26] Ribavirin monotherapy for hepatitis C virus-associated membranous nephropathy
    Hu, SL
    Jaber, BL
    CLINICAL NEPHROLOGY, 2005, 63 (01) : 41 - 45
  • [27] Membranous nephropathy and autoimmune hepatitis in the setting of acute Helicobacter pylori infection: a case report
    Zeid Nesheiwat
    Judy Daboul
    Ganesh Prasad Merugu
    Sreedhar Adapa
    Mamtha Balla
    Journal of Medical Case Reports, 15
  • [28] Hepatitis B virus reactivation after successful treatment of hepatitis C virus with sofosbuvir and ribavirin A case report and literature review
    Miyasaka, Akio
    Yoshida, Yuichi
    Suzuki, Akiko
    Masuda, Tomoyuki
    Okamoto, Hiroaki
    Takikawa, Yasuhiro
    MEDICINE, 2020, 99 (41) : E22650
  • [29] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Shoreibah, Mohamed
    Orr, Jordan
    Jones, DeAnn
    Zhang, Jie
    Venkata, Krishna
    Massoud, Omar
    HEPATOLOGY INTERNATIONAL, 2017, 11 (05) : 434 - 439
  • [30] Ledipasvir and sofosbuvir:Interferon free therapy for hepatitis C virus genotype 1 infection
    Yasir Waheed
    World Journal of Virology, 2015, (01) : 33 - 35
12345